TLR5 and breast cancer: For instance, it is suggested that activation of TLR5 by S. typhimurium flagellin in BC cells mediates the pro-inflammatory responses to obtain an effective anti-tumor activity, which may serve as a novel therapeutic target for BC therapy (122).